Because there are no evidence-based studies on duration of the interval between discontinuation of a previous therapy and a new biologic, treatment decisions should depend on the treatment that is being discontinued, disease severity, and response to prior treatment.
Other recommendations for the treatment of moderate to severe plaque psoriasis include the use of etanercept, infliximab, adalimumab, or ustekinumab as monotherapy or combined with other agents.
Learn more about the treatment of psoriasis.
Editor's Recommendations
Medscape © 2023 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Dirk M Elston, William James. Fast Five Quiz: What Do You Know About Psoriasis? - Medscape - Jan 25, 2023.
Comments